Holding(s) in Company

RNS Number : 5809M

Shield Therapeutics PLC

12 January 2023

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)  i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are at- tached ii :			Shield Therapeutics plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights						x
Other (please specify) iii :
3. Details of person subject to the notification obligation iv
Name			W. Health L.P. ("Inventages")
City and country of registered office (if applicable)			The Bahamas
4. Full name of shareholder(s) (if different from 3.) v
Name			CGWL Nominees Limited
City and country of registered office (if applicable)			London, UK
5. Date on which the threshold was crossed or reached vi :			6 January 2023
6. Date on which issuer notified (DD/MM/YYYY):			11 January 2023
7. Total positions of person(s) subject to the notification obligation
	% of voting rights at- tached to shares (to- tal of 8. A)	% of voting rights through financial instru- ments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached	9.56%	0%		9.56%	56,008,541
Position of previous notification (if applicable)	21.76%	0%		21.76%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)	Number of voting rights ix		% of voting rights
	Direct (DTR5.1)	Indirect (DTR5.2.1)	Direct (DTR5.1)	Indirect (DTR5.2.1)
GB00BYV81293	56,008,541	0	9.56%	0%
SUBTOTAL 8. A	56,008,541		9.56%

B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial in- strument	Expiration date x	Exercise/ Conversion Period xi	Number of voting rights that may be acquired if the instrument is exercised/converted.	% of voting rights
		SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date x	Exercise/ Conversion Pe- riod xi	Physical or cash Settlement xii	Number of voting rights	% of voting rights
			SUBTOTAL 8.B.2

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii				x
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv
Name xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial in- struments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

Place of completion	The Bahamas
Date of completion	11 January 2023

 

END

 

 

HOLBTMITMTTBBJJ